Stay updated on Vahelva Respimat in Korean COPD Patients Clinical Trial
Sign up to get notified when there's something new on the Vahelva Respimat in Korean COPD Patients Clinical Trial page.

Latest updates to the Vahelva Respimat in Korean COPD Patients Clinical Trial page
- Check6 days agoChange DetectedThe page now shows Revision: v3.4.3. The previous Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2 to the page. Removed the previous government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a government funding notice about potential data updates and the NIH Clinical Center’s operating status, with a note to visit cc.nih.gov for details. Updated the page revision to v3.4.1, replacing the previous v3.4.0 tag.SummaryDifference0.4%

- Check48 days agoChange DetectedAdded glossary and related info sections, Boehringer Ingelheim, and Helpful Links; included IPD Sharing details with access criteria and links to study documents (Study Protocol, SAP, CSR). Removed No FEAR Act data entry.SummaryDifference54%

- Check56 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing v3.3.3. This appears to be an internal version update and does not affect study content or user-facing features.SummaryDifference0.1%

- Check84 days agoChange DetectedFooter now shows Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 have been removed.SummaryDifference0.1%

Stay in the know with updates to Vahelva Respimat in Korean COPD Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vahelva Respimat in Korean COPD Patients Clinical Trial page.